Skip to main content
Promino Nutritional Sciences Inc. logo

Promino Nutritional Sciences Inc. — Investor Relations & Filings

Ticker · MUSL ISIN · CA74290V2049 CSE Manufacturing
Open in API
Filings indexed 332 across all filing types
Latest filing 2026-05-22 Capital/Financing Update
Country CA Canada
Listing CSE MUSL

About Promino Nutritional Sciences Inc.

https://drinkpromino.com/

Promino Nutritional Sciences Inc. is a research-driven nutraceutical company specializing in the development and distribution of science-based, clinically proven nutritional products for muscle health and recovery. The company focuses on patented formulations of essential amino acids (EAAs) designed to optimize muscle protein synthesis (MPS). Its flagship product, Promino™, is a consumer supplement that delivers a precise ratio and potency of all nine EAAs, demonstrated to be significantly more effective than traditional protein sources like whey. Promino's products target athletes and individuals seeking metabolic health improvements. The company also explores clinical applications, such as retaining muscle mass in cancer patients undergoing chemotherapy.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 87% confidence The document is a corporate press release announcing the closing of the final tranche of a private placement – details on issuance of units, gross proceeds, use of proceeds, and hold periods. This clearly relates to capital raising and financing activities. It is neither a full report (10-K/IR) nor a regulatory certification or voting result. It falls under Capital/Financing Update (CAP).
2026-05-22 English
News release - English.pdf
Capital/Financing Update Classification · 85% confidence The document is a corporate press release announcing the closing of the third tranche of a private placement, detailing the issuance of units (shares and warrants), gross proceeds, use of proceeds, and related securities law disclosures. This clearly constitutes an update on the company’s fundraising activities and capital structure changes, fitting the “Capital/Financing Update” category rather than a pure regulatory filing or report. Therefore, the correct classification is CAP.
2026-05-21 English
News release - English.pdf
Regulatory Filings Classification · 40% confidence The document is a corporate press release announcing the renewal of a brand ambassador agreement and related share issuance. It does not contain financial statements, management discussion of results, voting results, proxy materials, or details of a regulated report filing. There is no fundraising or structured financing beyond the issuance of shares as part of a commercial contract. None of the specific filing categories (10-K, IR, ER, M&A, etc.) apply. As a general corporate announcement/press release, this falls into the fallback category for miscellaneous regulatory or corporate disclosures.
2026-05-19 English
News release - English.pdf
Capital/Financing Update Classification · 90% confidence The document is a press release announcing the closing of a second tranche of a private placement, detailing share and warrant issuance, finder’s fees, use of proceeds, and related securities law disclosures. This is a classic financing activity update (fundraising and capital structure change). It does not present financial results, management discussion, or act as a report publication announcement, but rather provides financing transaction details. Therefore, it fits the Capital/Financing Update category (CAP).
2026-05-16 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings
2026-05-12 English
News release - English.pdf
Regulatory Filings
2026-05-05 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.